Loading...
XJPX4205
Market cap1.94bUSD
Dec 26, Last price  
1,469.00JPY
1D
0.72%
1Q
5.80%
Jan 2017
27.30%
Name

Zeon Corp

Chart & Performance

D1W1MN
XJPX:4205 chart
P/E
9.86
P/S
0.80
EPS
148.99
Div Yield, %
2.63%
Shrs. gr., 5y
-0.78%
Rev. gr., 5y
2.52%
Revenues
382.28b
-1.63%
231,364,000,000263,074,000,000281,613,000,000302,925,000,000268,857,000,000225,878,000,000270,383,000,000262,842,000,000250,763,000,000296,427,000,000307,524,000,000295,647,000,000287,624,000,000332,682,000,000337,499,000,000321,966,000,000301,961,000,000361,730,000,000388,614,000,000382,279,000,000
Net income
31.10b
+194.27%
7,773,000,00015,249,000,00017,077,000,0009,092,000,0002,478,000,0005,020,000,00018,303,000,00019,127,000,00014,750,000,00019,650,000,00019,080,000,00018,079,000,00023,152,000,00013,056,000,00018,458,000,00020,201,000,00027,716,000,00033,413,000,00010,569,000,00031,101,000,000
CFO
47.41b
+230.22%
20,556,000,00026,948,000,00023,633,000,0008,197,000,00010,373,000,00042,956,000,00048,100,000,00032,009,000,00033,061,000,00036,396,000,00034,006,000,00047,599,000,00049,042,000,00054,462,000,00040,393,000,00028,430,000,00056,080,000,00033,140,000,00014,358,000,00047,413,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Jan 29, 2025

Profile

Zeon Corporation engages in the elastomers, specialty materials, and other businesses. The company offers synthetic rubbers, such as general-purpose rubbers for use in automobile tire applications; and various specialty rubbers, including NBR and hydrogenated NBR. It also provides synthetic latex comprising styrene-butadiene copolymer latex, polybutadiene, acrylonitrile butadiene copolymer latex, acrylate latex, and soap-free latex for use in processed paper, fiber treatment agents, adhesives, paints, and rubber gloves; and materials for adhesive tapes and hot melt adhesives, binder for traffic paints, and concrete admixtures. In addition, the company offers specialty chemicals, such as synthetic aroma chemicals for flavors and fragrances; cyclopentene, cyclopentanone, and other derivatives for chemical synthesis; intermediates for pharmaceuticals and agrochemicals; and solvents and cleaning agents. Further, it provides electronic materials, rechargeable battery materials, and toners for the production of semiconductors, etching gas, and materials used in rechargeable battery production; and specialty plastics that include cyclo olefin polymers and fine processed products with cyclo olefin polymer for use in optical lenses, medical devices, and various general-purpose engineering plastics. Additionally, the company develops, manufactures, and sells cardiovascular and gastrointestinal medical equipment, as well as nutritional products; and licenses butadiene recovery and butene purification process technologies in approximately 23 countries worldwide. It also offers PENTAM, a resource- and energy-saving molded product. The company was founded in 1950 and is headquartered in Tokyo, Japan.
IPO date
Sep 11, 1961
Employees
4,293
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
382,279,000
-1.63%
388,614,000
7.43%
361,730,000
19.79%
Cost of revenue
361,779,000
361,435,000
317,298,000
Unusual Expense (Income)
NOPBT
20,500,000
27,179,000
44,432,000
NOPBT Margin
5.36%
6.99%
12.28%
Operating Taxes
12,847,000
3,858,000
12,520,000
Tax Rate
62.67%
14.19%
28.18%
NOPAT
7,653,000
23,321,000
31,912,000
Net income
31,101,000
194.27%
10,569,000
-68.37%
33,413,000
20.55%
Dividends
(8,055,000)
(7,013,000)
(5,250,000)
Dividend yield
2.88%
2.37%
1.76%
Proceeds from repurchase of equity
14,192,000
(5,498,000)
BB yield
-4.79%
1.85%
Debt
Debt current
8,960,000
27,960,000
18,960,000
Long-term debt
1,702,000
1,877,000
1,208,000
Deferred revenue
Other long-term liabilities
22,938,000
20,701,000
20,930,000
Net debt
(120,838,000)
(107,388,000)
(114,653,000)
Cash flow
Cash from operating activities
47,413,000
14,358,000
33,140,000
CAPEX
(33,670,000)
(27,309,000)
(24,173,000)
Cash from investing activities
(5,428,000)
(28,899,000)
(26,436,000)
Cash from financing activities
(30,085,000)
(2,820,000)
(11,883,000)
FCF
(6,009,000)
1,757,000
(406,000)
Balance
Cash
42,784,000
30,082,000
47,271,000
Long term investments
88,716,000
107,143,000
87,550,000
Excess cash
112,386,050
117,794,300
116,734,500
Stockholders' equity
363,582,000
631,882,000
618,724,000
Invested Capital
283,241,950
267,276,700
237,947,500
ROIC
2.78%
9.23%
14.57%
ROCE
5.16%
7.02%
12.41%
EV
Common stock shares outstanding
211,399
211,738
218,212
Price
1,321.00
-5.58%
1,399.00
2.57%
1,364.00
-22.89%
Market cap
279,257,891
-5.73%
296,221,462
-0.48%
297,641,168
-23.13%
EV
159,681,891
484,431,462
479,125,168
EBITDA
40,623,000
47,561,000
65,901,000
EV/EBITDA
3.93
10.19
7.27
Interest
68,000
85,000
130,000
Interest/NOPBT
0.33%
0.31%
0.29%